The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...
Optimed focuses on the global research, development, production, and distribution of devices for minimally invasive therapies ...
For many healthtech innovators the real adoption challenge is not always in proving the clinical value of their product. It is overcoming structural barriers that stand in their way. So, let’s explore ...
Bernard Ross, CEO of Sky Medical Technology, outlines how the NHS can ease pressures in chronic wound care management.
In the latest webinar of HealthLeaders' The Winning Edge series, a three-member panel will explore clinical care technology beyond artificial intelligence. In recent years, artificial intelligence has ...
Suki and Google Cloud are advancing clinical support technology to include patient summaries and a question-and-answer functionality. The collaboration focuses on Suki’s flagship product, Suki Assist, ...
PHOENIX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology leader in regenerative medicine, is pleased to announce the successful completion ...
At Inventus, we believe in creating solutions that simplify the complexities of device provisioning in the world of clinical trials. Founded in 2020, we are the world’s only Original Equipment ...
As the Centers for Medicare & Medicaid Services ratchets up its expectations of medical directors, data reflecting their responsibilities and the time they spend influencing nursing home care is ...
Nexalin Technology announces the shipment of HALO™ Clarity devices to UCSD for a clinical trial on mTBI and PTSD treatment. Nexalin Technology, Inc. has announced that the University of California, ...
Fiza Shaukat is a native of Pakistan living in the United States. As a biomedical engineer, she was eager to improve her country’s medical devices and digital health strategies. She approached us in ...